Company Relief Therapeutics Holding AG Other OTC
Equities
RLFTF
CH0100191136
Biotechnology & Medical Research
Business Summary
Sales per Business
CHF in Million | 2021 | Weight | 2022 | Weight | Delta |
---|---|---|---|---|---|
Biopharmaceutical Products
100.0
%
| 3 | 100.0 % | 6 | 100.0 % | +83.11% |
Sales per region
CHF in Million | 2021 | Weight | 2022 | Weight | Delta |
---|---|---|---|---|---|
Europe (excluding Switzerland)
39.7
%
| 1 | 33.6 % | 2 | 39.7 % | +116.32% |
North America
27.9
%
| 1 | 25.1 % | 2 | 27.9 % | +103.47% |
Rest of the World
19.2
%
| 1 | 25.4 % | 1 | 19.2 % | +38.63% |
Switzerland
13.2
%
| 1 | 15.9 % | 1 | 13.2 % | +51.80% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Michelle Lock
CEO | Chief Executive Officer | - | 22-01-27 |
Jeremy Meinen
DFI | Director of Finance/CFO | - | - |
Ram Selvaraju
CHM | Chairman | 46 | 16-05-24 |
Paolo Galfetti
COO | Chief Operating Officer | - | 21-05-26 |
Anthony M. Kim
PRN | Corporate Officer/Principal | - | 21-11-30 |
Marco Marotta
PRN | Corporate Officer/Principal | - | 21-11-29 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Ram Selvaraju
CHM | Chairman | 46 | 16-05-24 |
Paolo Galfetti
COO | Chief Operating Officer | - | 21-05-26 |
Thomas Plitz
BRD | Director/Board Member | 56 | 20-12-16 |
Patrice Jean
BRD | Director/Board Member | - | 21-05-26 |
Michelle Lock
CEO | Chief Executive Officer | - | 22-01-27 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 14,040,837 | 9,248,182 ( 65.87 %) | 1,822,398 ( 12.98 %) | 65.87 % |
Holdings
Name | Equities | % | Valuation |
---|---|---|---|
1,822,398 | 12.98% | 2,630,303 $ |
Company contact information
RELIEF THERAPEUTICS Holding SA
Avenue de Sécheron 15 Bâtiment F2/F3
1202, Geneva
+
http://www.relieftherapeutics.comSector
Sales per region
1st Jan change | Capi. | |
---|---|---|
+1.92% | 42.59B | |
+8.51% | 40.65B | |
+49.22% | 40.57B | |
-12.36% | 26.77B | |
+8.60% | 24.81B | |
-24.01% | 18.17B | |
+28.74% | 12.05B | |
-3.01% | 11.7B | |
+6.80% | 11.1B |